Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Prospective Diagnostic Test: Screening and Differentiating Common Cancers (Cancers of Lung, Stomach, Colorectum, Esophagus, Liver, Breast and Pancreas) Based on Peripheral Blood Cell-Free DNA Sequencing

NCT06036563 is registered in ClinicalTrials.gov with Air Force Military Medical University, China as lead sponsor.

NCT NCT06036563
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06036563 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Prospective Diagnostic Test: Screening and Differentiating Common Cancers (Cancers of Lung, Stomach, Colorectum, Esophagus, Liver, Breast and Pancreas) Based on Peripheral Blood Cell-Free DNA Sequencing
Lead sponsor
Air Force Military Medical University, China
Phase
Observational
Overall status
Unknown status
Start date
September 1, 2023
Completion date
December 31, 2025
Enrollment
3,200 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, cancer diagnosis, colorectal cancer, esophagus cancer, gastric cancer, liver cancer, lungcancer, pancreas cancer